Summary results of WHO product testing of malaria RDTs: round 1-7 (2008–2016)
Editor: Elisabeth Heseltine
World Health Organization, 2017
WHO recommends that malaria case management be based on parasite diagnosis in all cases. The use of antigendetecting rapid diagnostic tests (RDTs) is a vital part of this strategy, forming the basis for extending access to malaria diagnosis by providing parasite-based diagnosis in areas where good-quality microscopy cannot be maintained. Therefore, in 2006, the WHO Special Programme for Research and Training in Tropical Diseases (TDR) and the Foundation for Innovative New Diagnostics (FIND) launched a programme to systematically evaluate and compare the performance of commercially available malaria RDTs. The data have guided procurement decisions, which, in turn, have shifted markets towards better-performing tests and are driving overall improvements in the quality of manufacturing.